Factors associated with persistent smoking after the diagnosis of cardiovascular disease

Hyo-Eun Kim1, Yun-Mi Song, Bo-Kyoung Kim

  • 1Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Many cardiovascular disease (CVD) survivors continue smoking after diagnosis. Factors like regular drinking and family smoking habits increase this risk, while lower education and diabetes may reduce it.

Area of Science:

  • Cardiology
  • Public Health
  • Behavioral Science

Background:

  • Cigarette smoking is a primary modifiable risk factor for cardiovascular disease (CVD).
  • A significant number of CVD survivors struggle to quit smoking post-diagnosis.
  • Factors influencing smoking cessation after CVD events remain underexplored.

Purpose of the Study:

  • To identify factors associated with continued smoking behavior after a cardiovascular disease (CVD) diagnosis.
  • To analyze the relationship between socioeconomic, behavioral, and clinical characteristics and smoking cessation in CVD patients.

Main Methods:

  • Utilized data from 16,807 participants in the fourth Korean National Health and Nutrition Examination Surveys.
  • Selected 180 participants with a prior CVD diagnosis (angina, myocardial infarction, stroke) who were active smokers at diagnosis.
  • Employed logistic regression to assess multivariable-adjusted associations with smoking cessation post-CVD.

Main Results:

  • Over 63% of CVD patients continued smoking after diagnosis.
  • Regular drinking (OR=4.44) and having smoking family members (OR=5.86) significantly increased the risk of persistent smoking.
  • Lower education (OR=0.20), heavier smoking (OR=0.95), longer time since diagnosis (OR=0.88), and diabetes (OR=0.36) were associated with decreased risk of continued smoking.

Conclusions:

  • A substantial proportion of Korean CVD patients persist in smoking.
  • Tailored interventions considering patient characteristics are crucial for effective smoking cessation.
  • More aggressive smoking cessation strategies are needed for CVD survivors to reduce public health burden.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: